Literature DB >> 18713591

Necrolytic acral erythema: a case not associated with hepatitis C infection.

Austin Liu1, Christof P Erickson, Clay J Cockerell, Sylvia Hsu.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18713591

Source DB:  PubMed          Journal:  Dermatol Online J        ISSN： 1087-2108


× No keyword cloud information.
  8 in total

1.  Seronegative necrolytic acral erythema: a distinct clinical subset?

Authors:  S Panda; K Lahiri
Journal:  Indian J Dermatol       Date:  2010 Jul-Sep       Impact factor: 1.494

2.  Diagnosing necrolytic acral erythema: does anything go?

Authors:  Jayanta Kumar Das
Journal:  Indian J Dermatol       Date:  2011-03       Impact factor: 1.494

3.  Authors' reply.

Authors:  Saumya Panda; Koushik Lahiri
Journal:  Indian J Dermatol       Date:  2011-03       Impact factor: 1.494

Review 4.  Necrolytic acral erythema as a cutaneous marker of hepatitis C: report of two cases and review.

Authors:  James H Tabibian; Meg R Gerstenblith; Ryan J Tedford; Jacqueline M Junkins-Hopkins; Rachel Abuav
Journal:  Dig Dis Sci       Date:  2010-05-26       Impact factor: 3.487

5.  Zinc-responsive acral hyperkeratotic dermatosis-A novel entity or a subset of some well-known dermatosis?

Authors:  Arghyaprasun Ghosh; Ishad Aggarwal; Abhishek De; Ayan Samanta; Gobinda Chatterjee; Sanchaita Bala; Projna Biswas; Nidhi Chowdhary
Journal:  Indian J Dermatol       Date:  2015 Mar-Apr       Impact factor: 1.494

6.  Seronegative necrolytic acral erythema: A report of two cases and literature review.

Authors:  Vishalakshi S Pandit; Arun C Inamadar; Aparna Palit
Journal:  Indian Dermatol Online J       Date:  2016 Jul-Aug

7.  Necrolytic Acral Erythema in Seronegative Hepatitis C.

Authors:  Ploychompoo Srisuwanwattana; Vasanop Vachiramon
Journal:  Case Rep Dermatol       Date:  2017-03-17

8.  Necrolytic Acral Erythema in the Absence of Hepatitis C Virus Infection.

Authors:  Anupam Das; Piyush Kumar; Ramesh C Gharami
Journal:  Indian J Dermatol       Date:  2016 Jan-Feb       Impact factor: 1.494
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.